Last reviewed · How we verify

NCT06974838

Explore the Therapeutic Effect of Theta Burst Stimulation on Emotion Regulation in Autism With Minimally Verbal Ability or Intellectual Disability

Not yet recruiting NA Last updated 16 May 2025
What this trial tests

NA trial testing intermittent theta burst stimulation in Autism Spectrum Disorder in 60 participants. Not yet recruiting.

Timeline
26 May 2025
Primary endpoint
30 June 2029
31 December 2029

Quick facts

Lead sponsorChang Gung Memorial Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date26 May 2025
Primary completion30 June 2029
Estimated completion31 December 2029
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 8 to 30, any sex, with Autism Spectrum Disorder or Minimally Verbal Ability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigator would like to investigate the impact of theta-burst stimulation over left DLPFC in autism with minimally verbal ability or intellectual disability

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of intermittent theta burst stimulation

Trials testing the same drug.

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06974838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing